Novel Drug Improves Rare Kidney Disorder in Phase 3 Trial
University of Minnesota Medical School
Some 42 percent of patients treated with sparsentan showed reduced proteinuria
Articles by University of Minnesota Medical School
Identifying Patients with Sarcoidosis at Risk for Bad Cardiac Outcomes
University of Minnesota Medical School
Patients with certain features seen on an MRI may benefit from an implantable cardioverter defibrillator
Study Establishes the Value of Cardiovascular MRI for Suspected Cardiac Tumors
University of Minnesota Medical School
The U of M Medical School study concludes that CMR should be the technique of choice